- Home
- TRVI vs THRM Comparison
TRVI vs THRM Comparison
Compare TRVI & THRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- THRM
- Stock Information
- Founded
- TRVI 2011
- THRM 1991
- Country
- TRVI United States
- THRM United States
- Employees
- TRVI N/A
- THRM N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- THRM Auto Parts:O.E.M.
- Sector
- TRVI Health Care
- THRM Consumer Discretionary
- Exchange
- TRVI Nasdaq
- THRM Nasdaq
- Market Cap
- TRVI 1.1B
- THRM 997.7M
- IPO Year
- TRVI 2019
- THRM 1993
- Fundamental
- Price
- TRVI $10.65
- THRM $34.13
- Analyst Decision
- TRVI Strong Buy
- THRM Buy
- Analyst Count
- TRVI 9
- THRM 3
- Target Price
- TRVI $20.72
- THRM $46.00
- AVG Volume (30 Days)
- TRVI 2.0M
- THRM 210.4K
- Earning Date
- TRVI 11-05-2025
- THRM 10-23-2025
- Dividend Yield
- TRVI N/A
- THRM N/A
- EPS Growth
- TRVI N/A
- THRM N/A
- EPS
- TRVI N/A
- THRM 1.02
- Revenue
- TRVI N/A
- THRM $1,453,370,000.00
- Revenue This Year
- TRVI N/A
- THRM $1.64
- Revenue Next Year
- TRVI N/A
- THRM $3.31
- P/E Ratio
- TRVI N/A
- THRM $33.74
- Revenue Growth
- TRVI N/A
- THRM N/A
- 52 Week Low
- TRVI $2.36
- THRM $22.75
- 52 Week High
- TRVI $11.11
- THRM $47.00
- Technical
- Relative Strength Index (RSI)
- TRVI 71.22
- THRM 45.56
- Support Level
- TRVI $9.29
- THRM $32.00
- Resistance Level
- TRVI $10.04
- THRM $34.65
- Average True Range (ATR)
- TRVI 0.57
- THRM 1.16
- MACD
- TRVI 0.07
- THRM -0.10
- Stochastic Oscillator
- TRVI 82.67
- THRM 52.08
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the United States, China, South Korea, Germany, Japan, the Czech Republic, and other countries.